Intra-Cellular Therapies, Inc. 4
4 · Intra-Cellular Therapies, Inc. · Filed Dec 7, 2016
Insider Transaction Report
Form 4
ALAFI MOSHE
10% Owner
Transactions
- Purchase
Common Stock
2016-12-07$16.14/sh+20,826$336,038→ 3,695,205 total(indirect: By LLC) - Purchase
Common Stock
2016-12-06$16.33/sh+44,174$721,445→ 3,674,379 total(indirect: By LLC)
Footnotes (3)
- [F1]The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $15.28 to $16.50 per share, inclusive.
- [F2]Mr. Alafi is a managing partner of Alafi Capital Company, LLC and may be deemed to beneficially own the shares held by Alafi Capital Company, LLC. Mr. Alafi disclaims beneficial ownership of the securities held by Alafi Capital Company, LLC except to the extent of his pecuniary interest therein.
- [F3]The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $15.91 to $16.37 per share, inclusive.